Skip to main content

acetaminophen

Generic: ACETAMINOPHEN·Brand: ACEPHEN, ACETAMINOPHEN, Acephen, Acetadryl, Allzital, Anabar, Anacin AF, Anacin Advanced Headache Formula, Apadaz, Arthriten Inflammatory Pain, Backaid, Backaid IPF, Backprin, Bactimicina, Bupap, By Ache, Capacet, Cetafen, Combogesic, Comtrex Sore Throat Relief, Contragesic, CounterAct Pain, Dologesic, Dvorah, Ed Flex, Endocet, Esgic, Exaprin, Exaprin Plus, Excedrin, Excedrin Back & Body, Excedrin Mild Headache, Excedrin PM, Excedrin PM Triple Action, Excedrin Quick Tab, Excedrin Tension Headache, Feverall, Fioricet, Fioricet with Codeine, Frenadol, Hycet, INFANTS' FEVERALL, INJECTAPAP, Legatrin PM, Little Fevers, Lorcet, Lortab, Mapap, Marten-Tab, NEOPAP, Nalocet, Ninjacof A, Norco, Nortemp, OFIRMEV, Pamprin Cramp Formula, Pamprin Max Formula, Pamprin Multi-Symptom, Panadol, Panadol Extra, Panadol PM, Percocet, Percogesic Reformulated Jan 2011, Pharbetol, Premsyn PMS, Primlev, Prolate, Redutemp, Relagesic, Repan, Ringl, Saleto, Sed-Max, TYLENOL, Tactinal, Tempra Quicklets, Tencon, Trezix, Tycolene, Tylenol, Tylenol Gelcap Extra Strength, Tylenol PM, Tylenol with Codeine, Ultracet, Unisom with Pain Relief, Vanatol, Vanquish, Verdrocet, Vtol, Zebutal

acetaminophen: 43 clinical trials tracked.

acetaminophen evidence translation

What we can confirm

43 tracked trials

No verified listed developer

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about acetaminophen, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence8 indications · 11 study sponsors
Clinical Trials (43)showing 10 most recent

Phase 2, Open-Label Study to Evaluate the Safety and Efficacy of MK-2010 in Combination With Sacituzumab Tirumotecan (Sac-TMT) in Participants With Advanced Solid Tumors

NCT07785609·Phase 2
Not yet recruiting

Primary endpoint: Number of Participants Who Experience an Adverse Event (AE)

Interventionalopen200 targetStarted 2026-09Completion 2031-09Merck Sharp & Dohme LLC

A Phase 2, Open-label, Multicenter Study to Determine the Safety, Tolerability, and Efficacy of MK-1045 in Participants With Hematologic Malignancies

NCT07709000·Phase 2
Not yet recruiting

Primary endpoint: Cohort A Part 1: Number of Participants Who Experience Dose-Limiting Toxicity (DLT)

Interventionalsingle60 targetStarted 2026-09Completion 2033-113 sites · IsraelMerck Sharp & Dohme LLC

A Phase 1, Investigator- and Participant-Blinded, Placebo-Controlled, Randomized, Multiple-Dose Study to Evaluate the Gastric Emptying Delay, Pharmacokinetics, Safety, and Tolerability of Eloralintide in Participants With Obesity or Overweight

NCT07738614·Phase 1·LLY
Recruiting

Primary endpoint: Acetaminophen Area Under the Concentration Versus Time Curve (AUC)

InterventionalRandomizeddouble56 targetStarted 2026-07Completion 2026-122 sites · Singapore, United StatesEli Lilly and Company

Comparing Pain Improvement for Intravenous Versus Oral Acetaminophen in Acute Pelvic Pain: A Randomized, Double-Blind, Double-Dummy Controlled Trial (PIVOTAL Trial)

NCT07595302·Phase 4
Not yet recruiting

Primary endpoint: Mean Change in Numeric Rating Scale (NRS) score

InterventionalRandomizedquadruple140 targetStarted 2026-07Completion 2027-061 site · United StatesMontefiore Medical Center

A Single-Centre, Open-Label Study of the Effect of UBT251 on Pharmacokinetics of an Oral Combination Contraceptive (Ethinylestradiol and Levonorgestrel) and Gastric Emptying in Women of Non-Childbearing Potential With Overweight or Obesity

NCT07710729·Phase 1·NVO
Recruiting

Primary endpoint: AUC,EE,SS: The area under the EE plasma concentration time curve during a dosing interval at steady state

Interventionalopen40 targetStarted 2026-07Completion 2027-041 site · CanadaNovo Nordisk A/S

A Phase 2/3, Randomized, Open-Label, Comparison Study of MK-1045 Versus Blinatumomab in Participants With Relapsed or Refractory CD19+ B-Cell Acute Lymphoblastic Leukemia (B-ALL)

NCT07570173·Phase 2/Phase 3
Recruiting

Primary endpoint: Percentage of Participants with Complete Remission (CR) in Study Part 1 and Part 2

InterventionalRandomizedsingle340 targetStarted 2026-05Completion 2033-1019 sites · Denmark, Greece, Israel, Italy…Merck Sharp & Dohme LLC

An Investigation of the Effect of NNC0662-0419 on Pharmacokinetics of an Oral Combination Contraceptive (Ethinylestradiol and Levonorgestrel) and Gastric Emptying in Women of Non-childbearing Potential With Overweight or Obesity

NCT07525791·Phase 1·NVO
Recruiting

Primary endpoint: Area under curve (AUC) 0-24 h, EE, steady state (SS): The area under the EE plasma concentration-time curve (pre-dose to 24 hours post-dose)

Interventionalopen45 targetStarted 2026-04Completion 2027-051 site · United StatesNovo Nordisk A/S

Effect of Ultrasound Guided Pecs Block With Intravenous Ketamine and Ketamine Infusion Alone For Prevention of Chronic Post-Surgical Pain in Patients Undergoing Breast Cancer Surgery: A Randomized Controlled Trial

Not yet recruiting

Primary endpoint: Frequency of Chronic Post-operative Pain

InterventionalRandomizedsingle120 targetStarted 2026-03Completion 2027-05Aga Khan University

Antipyretic Therapy With and Without Cold Sponging: A Comparative Study in Febrile Children.

Not yet recruiting

Primary endpoint: Fever reduction

InterventionalRandomizedopen210 targetStarted 2026-03Completion 2026-081 site · PakistanMuhammad Aamir Latif

Optimizing Pain Treatment in Children On Mechanical Ventilation

NCT06994442·Phase 3
Recruiting

Primary endpoint: Acute Pain Episodes

InterventionalRandomizedquadruple644 targetStarted 2025-12Completion 2029-0816 sites · United StatesWeill Medical College of Cornell University